Collectively, these data reported here support the conclusion that FAK enhances invasion of HNSCC by promoting both increased cell motility and MMP-2 production, thus providing new insights into possible therapeutic intervention strategies. The gene discussed is PTK2; the disease is head and neck squamous cell carcinoma.